Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

Boots Co PLC (AB.)

  Print      Mail a friend

Thursday 27 January, 2000

Boots Co PLC

New Stores to be Opened in Taiwan

Boots Co PLC
27 January 2000

Boots to open stores in Taiwan
The Boots Company today announced plans to trial its Boots
Health and Beauty stores in Taiwan.

Boots will open 5 stores in Taipei by the end of 2000.  Total
investment over the next 18 months will be of the order of

Boots has already established retail operations in Asia, with
a growing chain in Thailand and three recently opened pilot
stores in Tokyo.

The Health and Beauty format stores in Taiwan will closely
resemble Boots The Chemists UK stores and those already
established in Asia. Store appearance and layout will be
similar and they will stock OTC medicines and a wide range of
fragrance, cosmetics and toiletries. Merchandise will include
the major Boots brands and exclusives such as No7 cosmetics,
Ruby and Millie cosmetics and Natural Collection toiletries
plus international and leading local brands.

The Boots Company's chairman, Lord Blyth of Rowington said
'Once again we have thoroughly researched the market and
Taiwan represents a great opportunity to extend our
international retail business. We believe that the market has
the potential to support a chain of around 100 Boots stores
and we hope to build on our success in Thailand where we
expect to have 50 stores trading by the end of March.'

For Further Information Contact:

Keith Whitesides                       Francis Thomas
Director of Investor Relations         Group Media Relations Manager
The Boots Company PLC                  The Boots Company PLC
Tel: 0115 968 7171                     Tel: 0115 968 7029
                                       Mobile: 0836 660 700

Notes to Editors:

Taiwan has a population of 22 million mostly living in urban
areas around six major cities. The largest of these, Taipei,
has a population of over 7.5 million (including greater
Taipei). The Taiwanese retail market is worth around £30
billion per year concentrated in the major urban areas and
Taipei in particular.

The cosmetics and toiletries market is valued at around £1
billion (a quarter of the size of the UK market) and is
forecast to achieve growth in excess of 4% p.a. for the next 5

There is no single dominant cosmetics and toiletries retailer.
The country's 60 department stores, dominated by the major
Japanese chains, are the main outlet for premium cosmetics.
Toiletries are sold primarily through the grocery and
drugstore sectors, in which Carrefour and Watson's,
respectively, are the key players.

Management of the Boots Taiwan Business
The Boots Taiwan business will form part of the portfolio of
international retail businesses that comprise Boots Retail
International, a division of The Boots Company PLC.

The managing director of the Boots Taiwan business will be
Martin Waters. Prior to this appointment Mr Waters was the
marketing director of Boots Retail Thailand and previously
held a number of senior positions in Boots The Chemists and

Boots Other Overseas Retail Interests

Thailand: In May 1998 Boots announced plans to open a chain of
Health & Beauty stores in Thailand following a successful year
of trials involving six pilot stores. There are currently 39
stores trading.
The Netherlands: Boots announced plans in January 1999, to
open a chain of Boots Health and Beauty stores in the
Netherlands over the next four years. There are currently 14
stores trading.
Japan: In July 1998 Boots announced plans to establish pilot
stores in Tokyo and 3 stores were opened during the autumn of
Republic of Ireland: Boots opened its first store in Dublin in
1996. Following the acquisition of two pharmacy chains in
1998, Boots is now the largest pharmacy chain in the Irish
Republic with 29 stores.

Boots Other Overseas Operations

Boots Contract Manufacturing (BCM). The largest contract
manufacturer of cosmetics and toiletries in Europe.  In
addition to supplying cosmetics, toiletries and medicines to
its sister companies, BCM also develops and manufactures
products for retailers in the UK and overseas.  BCM has
manufacturing bases in England, Scotland, France, Germany and
Boots Healthcare International (BHI).  Develops and markets
over the counter medicines in over 130 countries world-wide.
Specialising in three core product categories; analgesics,
upper respiratory tract and dermatological skincare, BHI's
best known brands include Nurofen and Strepsils.  In recent
years BHI has added to its skincare portfolio with the
acquisition of Lutsia in France and Hermal in Germany.


a d v e r t i s e m e n t